Six of eight patients (75%) with HER2-positive rectal adenocarcinoma responded to trastuzumab and tucatinib plus chemotherapy ...

Large-Scale Pharmacogenomics Analysis of Patients With Cancer Within the 100,000 Genomes Project Combining Whole-Genome Sequencing and Medical Records to Inform Clinical Practice SOC was dominated by ...

A 55-year-old married Arab woman presented with a rapidly enlarging, painful mass in her right breast and had previously noted a small, stable mass in the same breast for 10 years. Examination ...

Although rectal cancer is a life-threatening disease, it is highly curable in its early stages. Depending on the location and state of the cancer, surgery may be required. To avoid life-altering ...

An MRI exam can identify residual disease and predict rectal patient outcomes, making it a useful resource to identify patients suitable for a watch-and-wait protocol, according to a study published ...

Colorectal adenocarcinoma incidence is decreasing overall but increasing among individuals aged 15 to 34 years, with an APC of 1.75. Pancreatic adenocarcinoma incidence is rising across all age groups ...

About The Study: The findings of this cohort study suggest that the incidence of pancreatic adenocarcinoma has increased among all age groups, whereas that of colorectal adenocarcinoma has increased ...